For the Inventor, By the Inventor

Enter assignee name

Utrecht, Netherlands

Umc Utrecht Holding B.v.

Calculating rank

USPTO Granted Patents = 53

% Expired Patents = 18.9

CIPO Patents = 6

EPO Patents = 37

Forward Citations = 61

Loading Chart...

Loading Chart...

115 inventors (with patents filed for the assignee):

Marc A Vos (4 out of 4 patents)

Jürgen Herbert Ernst Kuball (4 out of 9 patents)

Lucas Alphonsus Maria Evers (4 out of 10 patents)

4. Cornelis Korstiaan Van Der Ent (4 out of 4 patents)

5. Berthold Stegemann (3 out of 36 patents)

6. Alfonso Aranda Hernandez (3 out of 11 patents)

7. David J Sprenkeler (3 out of 3 patents)

8. Dennis Beringer (3 out of 3 patents)

9. Jeanette Henrica Wilhelmina Leusen (3 out of 5 patents)

10. Johannes Gerardus Maria Evers (3 out of 5 patents)

11. Geert Jan Van Tetering (3 out of 4 patents)

12. Johannes Carolus Clevers (3 out of 20 patents)

13. Jeffrey Matthijn Beekman (3 out of 3 patents)

14. Johanna Florentia Dekkers (3 out of 3 patents)

15. Martino Borgo (3 out of 4 patents)

Core Competencies:

Fusion Protein

Targeted Thrombolysis

Engineered IgA Antibodies

Nucleic Acid Molecules

MRI Systems

Cell Therapy

Cardiac Signal Detection

Antimicrobial Peptides

Surgical Devices

Biomarkers

Drug Combinations

Organ Models

53 patents: Sort by Forward Citations

1. 12636351 - FUSION PROTEIN FOR TARGETED THROMBOLYSIS FOR TREATMENT OF MICROVASCULAR THROMBOSIS (2026-05-26),

2. 12630650 - ENGINEERED IGA ANTIBODIES AND METHODS OF USE (2026-05-19),

3. 12528878 - Treatment Of IgE-Mediated Diseases With Antibodies That Specifically Bind CD38 (2026-01-20),

4. 12486531 - METHODS FOR PREPARING NUCLEIC ACID MOLECULES FOR SEQUENCING (2025-12-02),

5. 12370265 - Hydrogel for in-vivo release of medication (2025-07-29),

6. 12318756 - Macromolecular compositions comprising indene-derivatives, preparation thereof, and use thereof (2025-06-03),

7. 12297274 - Method of cell therapy (2025-05-13),

8. 12291749 - DNA methylation and genotype specific biomarker for predicting post-traumatic stress disorder (2025-05-06),

9. 12285201 - Tool system for removing prosthetic cement from a bone of a patient undergoing a joint prosthesis replacement operation (2025-04-29),

10. 12161669 - Compositions and methods for cell targeting therapies (2024-12-10),

11. 12144736 - Acetabular implant and method for deforming this implant (2024-11-19),

12. 11988661 - Rapid quantitative test to diagnose polycystic kidney disease (2024-05-21),

13. 11957388 - Deformable body and combination of such deformable body and a surgical screw element (2024-04-16),

14. 11918815 - Cardiac signal T-wave detection (2024-03-05),

15. 11867786 - Parameter map determination for time domain magnetic resonance (2024-01-09),

Company Overview

Umc Utrecht Holding B.V. is a prominent entity in the biomedical engineering sector, based in Utrecht, Netherlands. The organization specializes in the development of innovative medical technologies, focusing on advanced therapeutic solutions such as fusion proteins, targeted thrombolysis, and engineered IgA antibodies. Their research encompasses a range of cutting-edge topics, including nucleic acid molecules, MRI systems, cell therapy, cardiac signal detection, and antimicrobial peptides, contributing significantly to the advancement of healthcare and medical science.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

53 Patents

#4 in Utrecht

#154 in Netherlands

#13,357 in the World

Utrecht, Netherlands

Umc Utrecht Holding B.v.

Forward Citations = 61

115 inventors:

Marc A Vos (4 out of 4 patents)

Jürgen Herbert Ernst Kuball (4 out of 9 patents)

Lucas Alphonsus Maria Evers (4 out of 10 patents)

4. Cornelis Korstiaan Van Der Ent (4 out of 4 patents)

5. Berthold Stegemann (3 out of 36 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Umc Utrecht Holding B.v.. Retrieved from https://idiyas.com/company/umc-utrecht-holding-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…